Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

This Key Piece Of News Could Spark BioNTech, Moderna — And Stoke Demand For Covid Boosters

Covid vaccine stocks surged Friday after a new study suggested an added benefit of the updated omicron-targeting boosters.

Investors Business Daily

Uganda's Museveni vows no national lockdown as Ebola cases rise

Kampala (AFP) - Ugandan President Yoweri Museveni on Friday reiterated his refusal to impose a nationwide Covid-like lockdown to contain the spread of Ebola despite a worrying increase in cases.

AFP

An epidemic of fentanyl misinformation

More politicians say fentanyl should be deemed a "weapon of mass destruction." Do they even understand what it is?

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Europe OK's 1st one-dose drug to protect babies against RSV

The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year

The Independent UK

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth

Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line.

Investors Business Daily

Apellis Pharma Crashes On Unexpected Delay For Eye Drug, Taking A Key Rival With It

Apellis reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric with it.

Investors Business Daily

‘Vaccine apathy’ slowing down London’s Covid booster rollout

Top health professor warns that over-50s in London must be better protected heading into winter

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Healthtech and sustainable start-ups win Scottish innovation awards

Rebecca Goss from the University of St Andrews, who founded X-Genix, takes overall prize

Insider UK

EU approves preventative treatment for common infant virus

Paris (AFP) - The European Union has approved a preventative treatment for the very common virus that causes the chest infection bronchiolitis in infants, the companies that developed the drug said Friday.

AFP

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

China to make 'substantial' COVID policy changes soon - ex-govt expert

China will make substantial changes to its "dynamic-zero" COVID-19 policy in coming months, a former Chinese disease control official told a conference hosted by Citi on Friday, according to a recording of the session heard by Reuters.

Reuters

China's COVID policies are consistent and clear - China foreign ministry

Chinese foreign ministry spokesman Zhao Lijian said on Friday that he was not aware of the media report that said China was preparing a plan to end COVID-19 flight suspensions.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

General Mills latest to halt Twitter ads as Musk takeover sparks brand exodus

Cheerios and Lucky Charms cereal company joins General Motors Co and Audi among others in pulling money from the platform

ABC News

All the latest COVID-19 news and case numbers from around the states and territories

Here's a quick wrap of the COVID-19 news and case numbers from each Australian jurisdiction from the past week.

Investors Business Daily

Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts

Amgen stock popped Friday after the drugmaker sweetened its 2022 outlook following a third-quarter beat and strong Evenity sales.

The Independent UK

US agency softens opioid prescribing guidelines for doctors

The nation’s top public health agency has revised its guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

BioNTech Shares Up On Hope For Combined Flu, Covid Shot

Pfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock pare earlier Moderna-inspired losses.

The Independent UK

New York could get $524M under opioid settlements with Teva

New York Attorney General Letitia James says the state will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic

Reuters

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

The Independent UK

Pfizer starts early-stage trial of combined Covid and flu vaccine

The trial will look at the safety of the combined jab, how effective it is and whether patients suffer any side-effects

Wales Online

Pfizer trying a jab which protects against flu and Covid

The drug is being tested on 180 people aged 18 to 64

Investors Business Daily

Regeneron Sinks Despite Massive Earnings Beat On A Notable Blockbuster Miss

Regeneron Pharma topped third-quarter expectations Thursday, reporting less of a decline than expected. But REGN stock was down early.

The Street

Moderna Stock Tumbles On Softer Covid Vaccine Sales Forecast, Weakening Q3 Profits

Moderna cautioned Thursday that $2 billion to $3 billion of its vaccine sales could be pushed into next year amid broader supply chain challenges.

1 … 99 100 101 102

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations